Dr. Wellner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 W. 10th Ave.
Columbus, OH 43210Phone+1 614-293-6255Fax+1 614-293-1456
Education & Training
University of Louisville School of MedicineFellowship, Gastroenterology, 2015 - 2018
Ohio State University HospitalResidency, Internal Medicine, 2012 - 2015- Ohio State University College of MedicineClass of 2008
Certifications & Licensure
KY State Medical License 2015 - 2025
OH State Medical License 2012 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- 20 citationsCystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic FibrosisMitchell L. Ramsey, Yevgeniya Gokun, Lindsay A. Sobotka, Michael R. Wellner, Kyle Porter
The American Journal of Gastroenterology. 2021-10-19 - 5 citationsHigh-grade pancreatic intraepithelial lesions: prevalence and implications in pancreatic neoplasiaJean R. Park, Feng Li, Veeral M. Oza, Brett C. Sklaw, Kevin M. Cronley
Hepatobiliary & Pancreatic Diseases International. 2017-04-15 - 8 citationsCystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis.Mitchell L Ramsey, Michael R Wellner, Kyle Porter, Stephen E Kirkby, Susan S Li
World Journal of Hepatology. 2022-02-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
